Achieve Life Sciences, Inc. , a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom.
Achieve Life Sciences stock last closed at $3.25, down 2.11% from the previous day, and has decreased 36.15% in one year. It has overperformed other stocks in the Biotechnology industry by 0.4 percentage points. Achieve Life Sciences stock is currently +76.63% from its 52-week low of $1.84, and -38.79% from its 52-week high of $5.31.
At the moment, there are 34.69M shares of ACHV outstanding. The market value of ACHV is $112.73M. In the past 24 hours, 257,000 ACHV shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ACHV stock.
Based on our research, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, it's time to fill out some personal information so you are able to buy ACHV stock today.
Now that you've opened your account on apps for stocks, you can securely and quickly fund your account:
Watch this video walkthrough to see the process of depositing funds into your brokerage account.
After you have decided on the best place to buy Achieve Life Sciences stock, it's important to analyze their stock prior to buying, so you truly wrap your head around the risk and upside.
WallStreetZen was built to help average investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on ACHV's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge ACHV's true value.
Using relative valuations methods:
You can access additional valuation research on ACHV's stock here.
You can dig deeper into what analysts are projecting on the Achieve Life Sciences stock forecast page.
In the last 12 months, insiders at ACHV have bought more shares than they have sold.
Mark K. Oki, Chief Financial Officer of ACHV, was the latest ACHV insider to buy. They bought $28,890.00 worth of ACHV shares on Mar 17, 2025.
Get more info about who owns ACHV shares here.
No, Achieve Life Sciences doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two primary types of orders:
Hit the Open Trade button and eToro will execute the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Now that you own some shares in ACHV, you'll want to keep up with your new company.
Put ACHV on a watchlist to keep track of your ACHV stock.
To summarize, here are the 6 steps to buy Achieve Life Sciences stock:
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Achieve Life Sciences, add ACHV to your watchlist below.